Table II.
Correlation between miR-154 expression and clinicopathological parameters of baldder cancer.
| miR-154 expression | |||
|---|---|---|---|
| Clinical characteristics | Low | High | P-valuea |
| Age (years) | 0.914 | ||
| <60 | 19 | 17 | |
| ≥60 | 27 | 23 | |
| Sex | 0.279 | ||
| Male | 20 | 23 | |
| Female | 26 | 17 | |
| Tumor size (cm) | 0.363 | ||
| <3 | 28 | 29 | |
| ≥3 | 18 | 11 | |
| T stage | 0.020 | ||
| Ta/T1 | 8 | 8 | |
| T2 | 12 | 21 | |
| T3 | 18 | 10 | |
| T4 | 8 | 1 | |
| Histologic grade | 0.041 | ||
| G1 | 12 | 20 | |
| G2 | 17 | 13 | |
| G3 | 17 | 7 | |
| Lymph node metastasis | 0.024 | ||
| N0/1 | 19 | 28 | |
| N2 | 20 | 10 | |
| N3 | 7 | 2 | |
a
Pearson χ2 test was used to derive P-values. miR-154, microRNA-154.